Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Pfizer Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DACOMITINIB

Brand Name : VIZIMPRO

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2018-09-27

Application Number : 211288

Regulatory Info : RX

Registration Country : USA

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DACOMITINIB

Brand Name : VIZIMPRO

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2018-09-27

Application Number : 211288

Regulatory Info : RX

Registration Country : USA

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DACOMITINIB

Brand Name : VIZIMPRO

Dosage Form : TABLET;ORAL

Dosage Strength : 45MG

Packaging :

Approval Date : 2018-09-27

Application Number : 211288

Regulatory Info : RX

Registration Country : USA

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Dacomitinib Monohydrate

Brand Name : Vizimpro

Dosage Form : Film Coated Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 02/04/2019

Application Number : 20180212000013

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Dacomitinib Monohydrate

Brand Name : Vizimpro

Dosage Form : Film Coated Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 02/04/2019

Application Number : 20180212000020

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Dacomitinib Monohydrate

Brand Name : Vizimpro

Dosage Form : Film Coated Tablet

Dosage Strength : 45mg

Packaging :

Approval Date : 02/04/2019

Application Number : 20180212000037

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Dacomitinib Monohydrate

Brand Name : Vizimpro

Dosage Form : Film Coated Tablet

Dosage Strength : 30MG

Packaging :

Approval Date : 2019-05-23

Application Number : 1191354002

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Dacomitinib Monohydrate

Brand Name : Vizimpro

Dosage Form : Film Coated Tablet

Dosage Strength : 45MG

Packaging :

Approval Date : 2019-05-23

Application Number : 1191354003

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Dacomitinib Monohydrate

Brand Name : Vizimpro

Dosage Form : Film Coated Tablet

Dosage Strength : 15MG

Packaging :

Approval Date : 2019-05-23

Application Number : 1191354001

Regulatory Info : Authorized

Registration Country : Spain

blank